A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020-2021.
Snydman DR, McDermott LA, Thorpe CM, Goldstein EJC, Schuetz AN, Johnson S, Gerding DN, Gluck L, Bourdas D, Carroll KC, Lancaster CK, Garey KW, Wang Q, Walk ST, Duperchy E.
Snydman DR, et al. Among authors: gluck l.
Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0034923. doi: 10.1128/aac.00349-23. Epub 2023 Sep 20.
Antimicrob Agents Chemother. 2023.
PMID: 37728368
Free PMC article.